<?xml version="1.0" encoding="UTF-8"?>
<p>Endogenous and naturally occurring opioid peptides have continuously served as important leads for the design of peptide analogues, with a repertoire of structural modifications that can be targeted when exploring SARs or focusing on the improvement of their pharmacodynamics and the pharmacokinetics of peptide active compounds. Four research articles [
 <xref rid="B5-molecules-25-05658" ref-type="bibr">5</xref>,
 <xref rid="B6-molecules-25-05658" ref-type="bibr">6</xref>,
 <xref rid="B7-molecules-25-05658" ref-type="bibr">7</xref>,
 <xref rid="B8-molecules-25-05658" ref-type="bibr">8</xref>] focused on this subject.
</p>
